Intravenous paracetamol for closure of the ductus arteriosus after premature birth

Intravenous paracetamol for closure of the ductus arteriosus after premature birth - Intravenous paracetamol for closure of the ductus arteriosus after premature birth

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027018

Enrollment

Registered

2017-04-17

Start date

2017-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PDA

Interventions

Administration of paracetamol (dose of 15mg/kg every 6h for 3days)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Vely low birth weight infants who born from 23 to 31 weeks of gestational age and had failed and had contraindications to indomethacin therapy.

Exclusion criteria

Exclusion criteria: Infants who born less than 23weeks of gestational age or some or has some syndrome.

Design outcomes

Primary

Measure	Time frame
Pharmacologic closure of PDA	—

Countries

Japan

Contacts

Public ContactMatsumura Shun

Saitama Medical Center, Saitama Medical University Pediatrics

mshun1203@yahoo.co.jp049-228-3400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026